oxidopamine has been researched along with Atrophy in 8 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The influence of embryonic mesencephalic, striatal and mesencephalic/striatal co-grafts on amphetamine- and apomorphine-induced rotation behaviour was assessed in a rat model of multiple system atrophy/striatonigral degeneration type using dopamine D1 ([3H]SCH23390) and D2 ([3H]spiperone) receptor and dopamine re-uptake ([3H]mazindol) autoradiography." | 7.70 | Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesenc ( Granata, R; Jenner, P; Laboyrie, P; Poewe, W; Puschban, Z; Quinn, NP; Scherfler, C; Wenning, GK, 2000) |
| "The influence of embryonic mesencephalic, striatal and mesencephalic/striatal co-grafts on amphetamine- and apomorphine-induced rotation behaviour was assessed in a rat model of multiple system atrophy/striatonigral degeneration type using dopamine D1 ([3H]SCH23390) and D2 ([3H]spiperone) receptor and dopamine re-uptake ([3H]mazindol) autoradiography." | 3.70 | Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesenc ( Granata, R; Jenner, P; Laboyrie, P; Poewe, W; Puschban, Z; Quinn, NP; Scherfler, C; Wenning, GK, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Westphal, R | 1 |
| Sumiyoshi, A | 1 |
| Simmons, C | 1 |
| Mesquita, M | 1 |
| Wood, TC | 1 |
| Williams, SC | 1 |
| Vernon, AC | 1 |
| Cash, D | 1 |
| Kim, TW | 1 |
| Moon, Y | 1 |
| Kim, K | 1 |
| Lee, JE | 1 |
| Koh, HC | 1 |
| Rhyu, IJ | 1 |
| Kim, H | 1 |
| Sun, W | 1 |
| Sherren, N | 1 |
| Pappas, BA | 1 |
| Karagüzel, G | 1 |
| Gedikoğlu, G | 1 |
| Tanyel, FC | 1 |
| Büyükpamukçu, N | 1 |
| Hiçsönmez, A | 1 |
| Rosenblad, C | 1 |
| Kirik, D | 1 |
| Devaux, B | 1 |
| Moffat, B | 1 |
| Phillips, HS | 1 |
| Björklund, A | 1 |
| Puschban, Z | 1 |
| Scherfler, C | 1 |
| Granata, R | 1 |
| Laboyrie, P | 1 |
| Quinn, NP | 1 |
| Jenner, P | 1 |
| Poewe, W | 1 |
| Wenning, GK | 1 |
| Roghani, M | 1 |
| Behzadi, G | 1 |
| Finch, CE | 1 |
| Kohama, SG | 1 |
| Pasinetti, GM | 1 |
1 review available for oxidopamine and Atrophy
| Article | Year |
|---|---|
Ovarian steroid and neurotoxin models of brain aging in rodents.
Topics: Aging; Animals; Atrophy; Brain; Estrogens; Female; Mice; Mice, Inbred C57BL; Neurons; Neurotoxins; O | 1992 |
7 other studies available for oxidopamine and Atrophy
| Article | Year |
|---|---|
Characterization of gray matter atrophy following 6-hydroxydopamine lesion of the nigrostriatal system.
Topics: Animals; Apomorphine; Atrophy; Brain; Dopamine Agonists; Dopaminergic Neurons; Functional Laterality | 2016 |
Dissociation of progressive dopaminergic neuronal death and behavioral impairments by Bax deletion in a mouse model of Parkinson's diseases.
Topics: Animals; Apoptosis; Apoptosis Inducing Factor; Atrophy; bcl-2-Associated X Protein; Disease Models, | 2011 |
Selective acetylcholine and dopamine lesions in neonatal rats produce distinct patterns of cortical dendritic atrophy in adulthood.
Topics: Acetylcholine; Animals; Animals, Newborn; Antibodies, Monoclonal; Atrophy; Body Weight; Brain Chemis | 2005 |
Subsequent biological effects of chemical sympathectomy in rats undergoing unilateral testicular torsion.
Topics: Animals; Atrophy; Female; Fertility; Male; Necrosis; Oxidopamine; Pregnancy; Random Allocation; Rats | 1995 |
Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle.
Topics: Amphetamine; Animals; Antibodies; Apomorphine; Atrophy; Body Weight; Cerebral Ventricles; Corpus Str | 1999 |
Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesenc
Topics: Amphetamine; Animals; Apomorphine; Atrophy; Autoradiography; Behavior, Animal; Brain Tissue Transpla | 2000 |
Neuroprotective effect of vitamin E on the early model of Parkinson's disease in rat: behavioral and histochemical evidence.
Topics: Amphetamine; Animals; Apomorphine; Atrophy; Axonal Transport; Corpus Striatum; Disease Models, Anima | 2001 |